Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE:543635

₹158.98 -0.39 (-0.24%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

157.20

Today’s High

160.50

52W low

87.50

52W High

166.70

Open Price

160.50

Prev. Close

148.1000

Volume

1292451.00

Value

205473859.98

Fundamentals

Market Cap Cr

21076.70

Price to Earnings

1182.80

Price to Book Value

2.70

Dividend Yield

0.00

PE to Growth

10.80

Op Revenue TTM Cr

8171.16

Net Profit TTM Cr

17.82

Cash From Operating Activity Cr

1004.54

Return on Equity %

0.22

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

158.9

10Day EMA

157.8

12Day EMA

157.4

20Day EMA

155.7

26Day EMA

154.6

50Day EMA

150.5

100Day EMA

143.7

200Day EMA

133.6

5Day SMA

158.6

10Day SMA

157.9

20Day SMA

155.4

30Day SMA

153

50Day SMA

150.9

100Day SMA

141.3

150Day SMA

139.3

200Day SMA

130.6

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

42.4

Week

52.1

Month

50.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

159.98

PIVOT

First Resistance

161.79

Second Resistance

164.21

Third Resistance

166.02

First Support

157.56

Second Support

155.75

Third Support

153.33

Relative Strength Index

60.03

Money Flow Index

66.7

MACD

2.78

MACD Signal

2.64

Average True Range

4.74

Average Directional Index

25.86

Rate of Change (21)

6.53

Rate of Change (125)

15.03

Commodity Channel Index

108.2

Williams %R

-30.2

BETA

1 Month

0.42

3 Month

0.5

1 Year

0.56

3 Year

PRICE CHANGE ANALYSIS

↑ 1.33%

1 Week

Low

High

156.27

162.4

↑ 6.27%

1 Month

Low

High

136.1

162.5

↑ 17.55%

3 Months

Low

High

132.4

166.7

↑ 13.35%

6 Months

Low

High

114.35

166.7

↑ 76.47%

1 Year

Low

High

87.5

166.7

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 1578.49 1057.25 1083.32 873.11 1117.46 867.17 946.57 853.08 1202.38 606.33 863.52
Operating Expenses Qtr 1135.66 898.61 908.08 829.84 965.03 786.02 782.04 812.59 944.84 490.95 691.76
Operating Profit Qtr 389.64 125.53 86.16 16.59 89.55 27.27 46.83 -66.12 182.25 59.71 110.86
EBIDT Qtr Cr 442.83 158.64 175.24 43.27 152.43 81.15 157.57 40.49 257.54 117.99 171.76
Depreciation Qtr 52.50 51.56 50.83 50.37 53.01 47.19 47.11 44.78 51.38 5.93 37.54
Net Profit Qtr 273.08 74.34 77.16 -33.36 41.70 -2.42 47.33 -17.12 151.44 87.26 91.22
Basic EPS Qtr 2.06 0.56 0.61 -0.28 0.35 -0.02 0.40 -0.14 1.28 0.73 0.78
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 4592.17 3784.29 3318.54 3136.78
Operating Expenses Annual Cr 3772.19 3345.69 2697.65 2319.88
Operating Profit Annual 617.92 97.53 397.30 618.93
Operating Profit Margin Annual % 13.46 2.58 11.97 19.73
Total Expenses Annual Cr 4084.55 3653.64 2881.84 2468.23
EBIDT Annual Cr 819.98 438.60 620.89 816.90
EBIDT Annual margin % 17.86 11.59 18.71 26.04
Depreciation 205.26 192.08 130.64 143.64
PAT Before ExtraOrdinary Items Annual Cr 391.22 69.50 343.05 571.50
Net Profit Annual 391.22 69.50 343.05 571.50
Basic EPS Annual 3.05 0.58 2.91 9.11
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 6712.07 5261.79 5067.34 4100.62
Minority Interest Liability Annual Cr - - - -
Total Non Current Liabilities Annual Cr 610.99 829.32 623.84 184.38
Total Current Liabilities Annual Cr 2227.82 1951.29 1517.14 1471.67
Total Capital Plus Liabilities Annual Cr 9550.88 8042.40 7208.32 5756.67
Fixed Assets Annual 3022.10 3018.44 1814.08 1747.81
Total Non Current Assets Annual 6259.33 5693.72 5249.83 3989.17
Total Current Assets Annual 3291.55 2348.68 1958.49 1767.50
Total Assets Annual 9550.88 8042.40 7208.32 5756.67
Contingent Liabilities plus Commitments Annual Cr - 150.70 101.97 75.22
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual 358.29 71.52 255.20 34.72
Cash from Investing Activity Annual -635.52 -435.05 -1223.02 -4382.89
Cash from Financing Annual Activity 451.38 290.12 905.74 4494.16
Net Cash Flow Annual 174.15 -73.41 -62.08 145.99
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 50.73 44.09 42.73 41.23
ROE Annual % 5.82 1.32 6.76 13.93
ROCE Annual % 8.39 4.04 8.61 15.71
Total Debt to Total Equity Annual 0.17 0.31 0.22 0.04
EBDIT Annual Margin % 18.67 12.73 20.06 27.79
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 2578.74 2020.08 1960.57 1787.16 2188.08 1798.51 1766.23 1553.84 2209.50 1699.68 1595.45
Operating Expenses Qtr 2022.43 1690.20 1645.74 1616.53 1812.31 1628.64 1547.45 1464.91 1733.40 1313.53 1380.96
Operating Profit Qtr 529.93 268.37 265.64 132.32 351.27 87.33 172.56 17.08 397.96 225.59 196.57
EBIDT Qtr Cr 525.79 297.61 314.83 170.63 375.77 169.87 211.82 88.93 476.10 386.15 214.49
Depreciation Qtr 196.13 186.32 184.51 173.61 184.41 164.43 166.19 161.66 165.16 147.15 138.07
Net Profit Qtr 101.27 10.11 5.02 -98.58 50.11 -90.18 -37.34 -109.05 204.06 163.37 36.56
Basic EPS Qtr 0.77 0.08 0.04 -0.83 0.42 -0.76 -0.31 -0.92 1.72 1.30 0.31
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 8346.55 7306.66 6834.90 6479.01
Operating Expenses Annual Cr 6974.90 6453.31 5609.44 4886.94
Operating Profit Annual 1196.26 628.24 949.66 1427.96
Operating Profit Margin Annual % 14.33 8.60 13.89 22.04
Total Expenses Annual Cr 8163.96 7474.18 6393.87 5595.43
EBIDT Annual Cr 1371.65 853.35 1225.46 1592.07
EBIDT Annual margin % 16.43 11.68 17.93 24.57
Depreciation 740.57 676.69 586.18 545.04
PAT Before ExtraOrdinary Items Annual Cr -41.67 -240.79 316.93 787.79
Net Profit Annual 17.82 -186.46 375.96 835.03
Basic EPS Annual 0.14 -1.57 3.19 18.56
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 7911.37 6773.50 6696.60 5605.00
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 3031.14 3906.01 3067.10 2804.50
Total Current Liabilities Annual Cr 4369.30 3843.05 3033.34 2490.28
Total Capital Plus Liabilities Annual Cr 15311.81 14522.56 12797.04 10899.78
Fixed Assets Annual 7605.55 7779.67 7021.02 5875.67
Total Non Current Assets Annual 9847.34 9687.08 8729.82 7251.08
Total Current Assets Annual 5464.47 4835.48 4067.22 3648.70
Total Assets Annual 15311.81 14522.56 12797.04 10899.78
Contingent Liabilities plus Commitments Annual Cr - 305.78 365.47 203.55
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual 1004.54 483.89 766.42 597.58
Cash from Investing Activity Annual -434.01 -1338.78 -1812.10 -4479.93
Cash from Financing Annual Activity -422.36 817.79 794.19 3976.83
Net Cash Flow Annual 148.17 -37.10 -251.49 94.48
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 59.80 56.76 56.47 56.35
ROE Annual % 0.22 -2.75 5.61 14.89
ROCE Annual % 5.76 1.65 6.54 12.45
Total Debt to Total Equity Annual 0.58 0.81 0.60 0.48
EBDIT Annual Margin % 16.78 12.05 18.68 25.21
Name Holding Percent Holding Id Pledged % Locked %
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund 5.01 75061979 - -
Icici Prudential Value Discovery Fund 1.22 75061980 - -
East Bridge Capital Master Fund I Ltd 4.35 75061987 - -
Name Holding Percent Holding Id Pledged % Locked %
The Sri Krishna Trust through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A Piramal 26.67 75061914 0 0
V3 Designs LLP 3.25 75061915 0 0
PRL Realtors LLP 3.01 75061916 0 0
Piramal Welfare Trust (Formerly known as The Piramal Enterprise Executives Trust) 0.8 75061917 0 0
AASAN Corporate Solutions Pvt. Ltd 0.68 75061918 0 0
Name Holding Percent Holding Id
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund 5.01 75061979
Icici Prudential Value Discovery Fund 1.22 75061980
East Bridge Capital Master Fund I Ltd 4.35 75061987
Life Insurance Corporation Of India 1.85 75061982
Ca Alchemy Investments 18.04 75061990
Name Holding Percent Holding Id
Indiahold Limited 1.31 75061994
Overseas Corporate Bodies 1.31 75061995
LLP 0.92 75061996
HUF 0.65 75061997
Unclaimed or Suspense or Escrow Account 0.65 75061998
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Jul 12, 2024 0.11 FINAL Jul 12, 2024 Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 10, 2024 Audited Results & Final Dividend -
Jan 30, 2024 Quarterly Results -
Oct 27, 2023 Quarterly Results -
Aug 03, 2023 Quarterly Results -
May 24, 2023 Audited Results -
Feb 08, 2023 Quarterly Results & Rights issue -
Nov 08, 2022 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Bigul
03 Jul 2024

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please refer attachment.
Bigul
02 Jul 2024

Piramal Pharma Ltd - 543635 - Business Responsibility and Sustainability Reporting (BRSR)

 Business Responsibility and sustainability Report for the financial year ended 2023-24.
Bigul
02 Jul 2024

Piramal Pharma Ltd - 543635 - Reg. 34 (1) Annual Report.

 Notice of the 4th Annual General Meeting ('AGM') and Annual Report for the financial year 2023-24
Bigul
02 Jul 2024

Piramal Pharma Ltd - 543635 - Notice Of The 4Th Annual General Meeting ('AGM') And Annual Report For The Financial Year 2023-24

 Notice of the 4th Annual General meeting (''AGM'') and Annual Report for the financial year 2023-24
Bigul
21 Jun 2024

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Intimation under Regulation 30 and 47 of SEBI Listing Regulations - Newspaper Advertisement for information regarding 4th Annual General Meeting and Record date for Dividend.
Bigul
11 Jun 2024

Piramal Pharma Ltd - 543635 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')- Update On Litigation

 Intimation under regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") - Update on Litigation
Bigul
11 Jun 2024

Piramal Pharma Ltd - 543635 - Intimation Of Record Date For Payment Of Dividend

 Intimation of Record date for payment of Dividend.
Bigul
11 Jun 2024

Piramal Pharma Ltd - 543635 - Corporate Action-Board to consider Dividend

 Intimation of Record date for payment of Dividend.
Bigul
11 Jun 2024

Piramal Pharma Ltd - 543635 - Intimation Of 4Th Annual General Meeting - Friday, 26Th July, 2024

 Intimation of 4th Annual General Meeeting - Friday, 26th July, 2024
Bigul
04 Jun 2024

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
See all News

FAQs

The latest market price of Piramal Pharma Ltd. on NSE was Rs. 158.98 as of today.

The opening share price of Piramal Pharma Ltd. was Rs. 160.50 as of today.

The 52-week high share price of Piramal Pharma Ltd. was Rs. 166.70.

The 52 week low share price of Piramal Pharma Ltd. was Rs. 87.50.

Piramal Pharma Ltd. has a market cap of Rs. 21076.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Piramal Pharma Ltd. is 10.80. Please refer to the Fundamentals section for further details.

The operating revenue for Piramal Pharma Ltd. in the last FY was Rs.  8171.16 crore. Please refer to the Financials section for further details.

The Net Profit for Piramal Pharma Ltd. in the last FY was Rs. 17.82 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Piramal Pharma Ltd. was on 2024-07-12 for Rs. 0.11 per share. According to today’s share price, the dividend yield of Piramal Pharma Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Piramal Pharma Ltd..

Close

Let's Open Free Demat Account